BAP1 and ulnar-mammary syndrome: Mutations in BRCA-associated protein 1 (BAP1) are observed in over 80% of all UMs, and approximately 28% of patients with germline BAP1 alterations will develop a UM and usually result in metastasis within 5 years [5].